Overview

Ferumoxytol-enhanced Brain MRI in HIV-associated Neurocognitive Disorders

Status:
Completed
Trial end date:
2012-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to describe the radiologic findings on brain MRI after ferumoxytol administration in HIV-infected patients with cognitive impairment.
Phase:
Phase 1
Details
Lead Sponsor:
University of Hawaii
Collaborator:
Oregon Health and Science University
Treatments:
Ferrosoferric Oxide